---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-000865"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2024-02-12T23:59:59+00:00"
generated_at: "2026-06-06T04:12:57.458678+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma repurchases and cancels warrants for ~21.6M shares for $3.14M total

## Summary
- Bought back May 2023 warrants for 11,904,762 shares from Armistice Capital for $2,361,596; warrants cancelled.
- Bought back April 2022 warrants for 9,725,690 shares from holders for $0.08 each ($778,055 total); cancelled.
- Armistice Capital waived variable-rate transaction prohibition under the May 2023 securities purchase agreement.
- Combined repurchase eliminates potential dilution from ~21.6M shares; cash outlay ~$3.14M.

## SEC filing metadata
- accession: 0001683168-24-000865
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2024-02-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316824000865/0001683168-24-000865-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316824000865/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-000865
- JSON: https://secwatch.observer/filing/0001683168-24-000865.json
- Plain text: https://secwatch.observer/filing/0001683168-24-000865.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.